Massachusetts General Hospital Logo

Neuroendocrine and Pituitary
Tumor Clinical Center (NEPTCC) Bulletin

Winter 2019/2020 | Volume 25, Issue 1

Research Studies Available

Patients may qualify for research studies in the Neuroendocrine and Pituitary Tumor Clinical Center. We are currently accepting the following categories of patients for screening to determine study eligibility. Depending on the study, subjects may receive free testing, medication and/or stipends.

 

SUBJECTS STUDIES CONTACT
617-726-3870
Adults with active or treated acromegaly

Study with a once a month, add-on therapy for those uncontrolled on highest dose of somatostatin analogues

Studies for those on a somatostatin analogue or on combination therapy investigating a once daily, oral medication

Beverly MK Biller, MD

Karen Pulaski Liebert, RN


The Neuroendocrine and Pituitary Tumor Clinical Center is involved in many different research studies.

Types of studies and enrollment status changes frequently, so please call our
office (617-726-3870) or check our webpage (pituitary.mgh.harvard.edu) for more
information about potential studies which may not be listed here.